AI platform for $5.7B fetal monitoring market, FDA Breakthrough Designation

Baymatob is a medtech company revolutionising maternal care with Oli™, an AI-driven tool for early detection of pregnancy and labor complications. Backed by Perennial, and Scale Investors, Oli targets the $5.7B fetal monitoring market and has FDA Breakthrough Designation (expedited review) to improve outcomes and reduce costly interventions.